CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,504 | +39.1% | 2,400 | +118.2% | 0.00% | – |
| Q2 2023 | $2,519 | +151.6% | 1,100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,001 | – | 1,100 | +1000.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 1,100 | +10.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |